Characterization of a dextran–coated layered double hydroxide acetylsalicylic acid delivery system and its pharmacokinetics in rabbit

The aim of this study was to prepare a dextran–coated layered double hydroxide acetylsalicylic acid (DEX–LDH–ASA) delivery system by co-precipitation of LDH–ASA and its in-situ compositing with DEX. The structure of the system was investigated using X-ray diffraction (XRD), Fourier transform infrare...

Full description

Bibliographic Details
Main Authors: Li-e Dong, Guojing Gou, Lin Jiao
Format: Article
Language:English
Published: Elsevier 2013-12-01
Series:Acta Pharmaceutica Sinica B
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2211383513000890
id doaj-9a5a281afd16472cb4ab101cc3882e49
record_format Article
spelling doaj-9a5a281afd16472cb4ab101cc3882e492020-11-24T22:38:02ZengElsevierActa Pharmaceutica Sinica B2211-38352211-38432013-12-013640040710.1016/j.apsb.2013.09.003Characterization of a dextran–coated layered double hydroxide acetylsalicylic acid delivery system and its pharmacokinetics in rabbitLi-e DongGuojing GouLin JiaoThe aim of this study was to prepare a dextran–coated layered double hydroxide acetylsalicylic acid (DEX–LDH–ASA) delivery system by co-precipitation of LDH–ASA and its in-situ compositing with DEX. The structure of the system was investigated using X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR) and thermogravimetry (TG). Its in vitro drug release properties and in vivo pharmacokinetics in rabbit were also determined. The results show that the DEX–LDH–ASA system retained the crystal structure of LDH–ASA and gave a marked improvement in its dispersion. It also prolonged the release of ASA and shifted the release pattern from first-order to zero-order kinetics. The pharmacokinetics of ASA administered in the DEX–LDH–ASA system to rabbits produced two absorption peaks with a Cmax of 14.8±1.7 mg/L at 2.11±0.69 h and an elimination half-life of 2.25±0.84 h for the first peak. The fact that delivery of ASA in the DEX–LDH–ASA system was sustained with improved bioavailability indicates the potential of the system as a controlled release formulation with application to other drugs.http://www.sciencedirect.com/science/article/pii/S2211383513000890Controlled releaseAcetylsalicylic acidDextranLayered double hydroxidePharmacokineticsRabbit
collection DOAJ
language English
format Article
sources DOAJ
author Li-e Dong
Guojing Gou
Lin Jiao
spellingShingle Li-e Dong
Guojing Gou
Lin Jiao
Characterization of a dextran–coated layered double hydroxide acetylsalicylic acid delivery system and its pharmacokinetics in rabbit
Acta Pharmaceutica Sinica B
Controlled release
Acetylsalicylic acid
Dextran
Layered double hydroxide
Pharmacokinetics
Rabbit
author_facet Li-e Dong
Guojing Gou
Lin Jiao
author_sort Li-e Dong
title Characterization of a dextran–coated layered double hydroxide acetylsalicylic acid delivery system and its pharmacokinetics in rabbit
title_short Characterization of a dextran–coated layered double hydroxide acetylsalicylic acid delivery system and its pharmacokinetics in rabbit
title_full Characterization of a dextran–coated layered double hydroxide acetylsalicylic acid delivery system and its pharmacokinetics in rabbit
title_fullStr Characterization of a dextran–coated layered double hydroxide acetylsalicylic acid delivery system and its pharmacokinetics in rabbit
title_full_unstemmed Characterization of a dextran–coated layered double hydroxide acetylsalicylic acid delivery system and its pharmacokinetics in rabbit
title_sort characterization of a dextran–coated layered double hydroxide acetylsalicylic acid delivery system and its pharmacokinetics in rabbit
publisher Elsevier
series Acta Pharmaceutica Sinica B
issn 2211-3835
2211-3843
publishDate 2013-12-01
description The aim of this study was to prepare a dextran–coated layered double hydroxide acetylsalicylic acid (DEX–LDH–ASA) delivery system by co-precipitation of LDH–ASA and its in-situ compositing with DEX. The structure of the system was investigated using X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR) and thermogravimetry (TG). Its in vitro drug release properties and in vivo pharmacokinetics in rabbit were also determined. The results show that the DEX–LDH–ASA system retained the crystal structure of LDH–ASA and gave a marked improvement in its dispersion. It also prolonged the release of ASA and shifted the release pattern from first-order to zero-order kinetics. The pharmacokinetics of ASA administered in the DEX–LDH–ASA system to rabbits produced two absorption peaks with a Cmax of 14.8±1.7 mg/L at 2.11±0.69 h and an elimination half-life of 2.25±0.84 h for the first peak. The fact that delivery of ASA in the DEX–LDH–ASA system was sustained with improved bioavailability indicates the potential of the system as a controlled release formulation with application to other drugs.
topic Controlled release
Acetylsalicylic acid
Dextran
Layered double hydroxide
Pharmacokinetics
Rabbit
url http://www.sciencedirect.com/science/article/pii/S2211383513000890
work_keys_str_mv AT liedong characterizationofadextrancoatedlayereddoublehydroxideacetylsalicylicaciddeliverysystemanditspharmacokineticsinrabbit
AT guojinggou characterizationofadextrancoatedlayereddoublehydroxideacetylsalicylicaciddeliverysystemanditspharmacokineticsinrabbit
AT linjiao characterizationofadextrancoatedlayereddoublehydroxideacetylsalicylicaciddeliverysystemanditspharmacokineticsinrabbit
_version_ 1725714942001152000